A Guibal1, G Renosi2, A Rode3, J Y Scoazec4, O Guillaud5, L Chardon6, M Munteanu7, J Dumortier5, F Collin8, T Lefort2. 1. Service de radiologie, hôpital Édouard-Herriot, hospices civils de Lyon, 69437 Lyon, France; Service de radiologie, centre hospitalier de Perpignan, 20, avenue du Languedoc, 66046 Perpignan cedex 9, France. Electronic address: aymeric.guibal@gmail.com. 2. Service de radiologie, hôpital Édouard-Herriot, hospices civils de Lyon, 69437 Lyon, France. 3. Service de radiologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon, France. 4. Service d'anatomo-pathologie, hôpital Édouard-Herriot, hospices civils de Lyon, 69437 Lyon, France. 5. Fédération des spécialités digestives, hôpital Édouard-Herriot, hospices civils de Lyon, 69437 Lyon cedex 03, France. 6. Fédération de biochimie, hôpital Édouard-Herriot, hospices civils de Lyon, 69437 Lyon, France. 7. Hepatology research unit, biopredicitive, 75007 Paris, France. 8. Service de radiologie, centre hospitalier de Perpignan, 20, avenue du Languedoc, 66046 Perpignan cedex 9, France.
Abstract
OBJECTIVES: The goals of this study were to assess the diagnostic accuracy of shear wave elastography (SWE) using the results of histopathological analysis as a standard of reference and compare the results of SWE and those of transient elastography (TE) to the degree of fibrosis as evaluated by histomorphometry. PATIENTS AND METHODS: Adult patients who were scheduled to undergo liver biopsy were prospectively enrolled in the study. The diagnostic performances of SWE were assessed using AUROC curve analysis according to fibrosis thresholds defined by ≥F2 (significant fibrosis), ≥F3 (advanced fibrosis) and F4 (cirrhosis). Additional analyses using the Obuchowski measures for pairwise comparisons of fibrosis stages were performed. In a subgroup of 55 patients, the relationships between stiffness as measured using SWE and TE and the percentage of fibrosis were compared using Spearman's rank coefficient. RESULTS: Among the initially enrolled 170 patients, 148/170 (87%) had successful SWE acquisition and formed the study population. SWE sensitivity and specificity were respectively 85.1% and 82.7% (≥F2), 88.9% and 90.3% (≥F3), 93.3% and 98.3% (F4). The AUROC curves of SWE along with their 95% confidence intervals (CI) were respectively 0.904 (95%CI: 0.845-0.946) for fibrosis ≥F2; 0.958 (95%CI: 0.912-0.984) for fibrosis ≥F3 and 0.988 (95%CI: 0.955-0.999) for fibrosis=F4. The global Obuchowski measure was 0.953±0.007. In the subgroup study, a significant correlation was found between the percentage of fibrosis and stiffness as assessed by SWE (r=0.77; 95%CI: 0.63-0.86; P<0.0001) and by TE (r=0.65; 95%CI: 0.47-0.78; P<0.01). CONCLUSION: SWE is accurate to assess liver fibrosis in patients with chronic liver disease.
OBJECTIVES: The goals of this study were to assess the diagnostic accuracy of shear wave elastography (SWE) using the results of histopathological analysis as a standard of reference and compare the results of SWE and those of transient elastography (TE) to the degree of fibrosis as evaluated by histomorphometry. PATIENTS AND METHODS: Adult patients who were scheduled to undergo liver biopsy were prospectively enrolled in the study. The diagnostic performances of SWE were assessed using AUROC curve analysis according to fibrosis thresholds defined by ≥F2 (significant fibrosis), ≥F3 (advanced fibrosis) and F4 (cirrhosis). Additional analyses using the Obuchowski measures for pairwise comparisons of fibrosis stages were performed. In a subgroup of 55 patients, the relationships between stiffness as measured using SWE and TE and the percentage of fibrosis were compared using Spearman's rank coefficient. RESULTS: Among the initially enrolled 170 patients, 148/170 (87%) had successful SWE acquisition and formed the study population. SWE sensitivity and specificity were respectively 85.1% and 82.7% (≥F2), 88.9% and 90.3% (≥F3), 93.3% and 98.3% (F4). The AUROC curves of SWE along with their 95% confidence intervals (CI) were respectively 0.904 (95%CI: 0.845-0.946) for fibrosis ≥F2; 0.958 (95%CI: 0.912-0.984) for fibrosis ≥F3 and 0.988 (95%CI: 0.955-0.999) for fibrosis=F4. The global Obuchowski measure was 0.953±0.007. In the subgroup study, a significant correlation was found between the percentage of fibrosis and stiffness as assessed by SWE (r=0.77; 95%CI: 0.63-0.86; P<0.0001) and by TE (r=0.65; 95%CI: 0.47-0.78; P<0.01). CONCLUSION: SWE is accurate to assess liver fibrosis in patients with chronic liver disease.
Authors: Eva Herrmann; Victor de Lédinghen; Christophe Cassinotto; Winnie C-W Chu; Vivian Y-F Leung; Giovanna Ferraioli; Carlo Filice; Laurent Castera; Valérie Vilgrain; Maxime Ronot; Jérôme Dumortier; Aymeric Guibal; Stanislas Pol; Jonel Trebicka; Christian Jansen; Christian Strassburg; Rongqin Zheng; Jian Zheng; Sven Francque; Thomas Vanwolleghem; Luisa Vonghia; Emanuel K Manesis; Pavlos Zoumpoulis; Ioan Sporea; Maja Thiele; Aleksander Krag; Claude Cohen-Bacrie; Aline Criton; Joel Gay; Thomas Deffieux; Mireen Friedrich-Rust Journal: Hepatology Date: 2017-11-15 Impact factor: 17.425
Authors: Hae Won Yoo; Sang Gyune Kim; Jae Young Jang; Jeong-Ju Yoo; Soung Won Jeong; Young Seok Kim; Boo Sung Kim Journal: Korean J Intern Med Date: 2021-12-07 Impact factor: 2.884
Authors: Marcella Massimini; Alessia Gloria; Mariarita Romanucci; Leonardo Della Salda; Lucia Di Francesco; Alberto Contri Journal: Vet Sci Date: 2022-09-15